LXEO
Income statement / Annual
Last year (2023), Lexeo Therapeutics, Inc. Common Stock's total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, Lexeo Therapeutics, Inc. Common Stock's net income was -$66.39 M.
See Lexeo Therapeutics, Inc. Common Stock’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00
|
$654,000.00
|
$1.66 M
|
$518,476.00
|
| Cost of Revenue |
$1.84 M |
$1.15 M |
$13,405.00 |
$0.00 |
| Gross Profit |
-$1.84 M |
-$491,000.00 |
$1.64 M |
$518,476.00 |
| Gross Profit Ratio |
0 |
-0.75 |
0.99 |
1 |
| Research and Development
Expenses |
$53.13 M
|
$49.16 M
|
$45.12 M
|
$4.32 M
|
| General & Administrative
Expenses |
$15.38 M
|
$12.00 M
|
$7.17 M
|
$787,499.00
|
| Selling & Marketing
Expenses |
-$1.84 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$13.54 M
|
$12.00 M
|
$7.17 M
|
$787,499.00
|
| Other Expenses |
$0.00 |
-$2,000.00 |
-$155.00 |
$4,241.00 |
| Operating Expenses |
$68.51 M |
$61.16 M |
$52.29 M |
$5.11 M |
| Cost And Expenses |
$68.51 M |
$61.16 M |
$52.29 M |
$5.11 M |
| Interest Income |
$2.87 M |
$1.33 M |
$15,000.00 |
$0.00 |
| Interest Expense |
$205,000.00 |
$91,000.00 |
$0.00 |
$147,150.00 |
| Depreciation &
Amortization |
$1.84 M
|
$1.15 M
|
$13,405.00
|
$4,241.00
|
| EBITDA |
-$66.67 M
|
-$58.04 M
|
-$50.62 M
|
-$4.58 M
|
| EBITDA Ratio |
0 |
-88.75 |
-30.54 |
-8.84 |
| Operating Income Ratio
|
0
|
-92.52
|
-30.56
|
-8.85
|
| Total Other
Income/Expenses Net |
$2.12 M
|
$1.23 M
|
$15,000.00
|
-$565,000.00
|
| Income Before Tax |
-$66.39 M |
-$59.28 M |
-$50.62 M |
-$5.15 M |
| Income Before Tax Ratio
|
0
|
-90.64
|
-30.55
|
-9.94
|
| Income Tax Expense |
$0.00 |
$89,000.00 |
-$155.00 |
$147,150.00 |
| Net Income |
-$66.39 M |
-$59.28 M |
-$50.62 M |
-$5.15 M |
| Net Income Ratio |
0 |
-90.64 |
-30.55 |
-9.94 |
| EPS |
-2.49 |
-2.4 |
-2.05 |
-0.21 |
| EPS Diluted |
-2.49 |
-2.4 |
-2.05 |
-0.21 |
| Weighted Average Shares
Out |
$26.65 M
|
$24.67 M
|
$24.67 M
|
$24.67 M
|
| Weighted Average Shares
Out Diluted |
$26.65 M
|
$24.67 M
|
$24.67 M
|
$24.67 M
|
| Link |
|
|
|
|
